Preputial Graft Urethroplasty in Primary Repair of Hypospadias
Launched by SARAH MAGDY ABDELMOHSEN · Dec 13, 2022
Trial Information
Current as of January 16, 2025
Completed
Keywords
ClinConnect Summary
Patients and methods This study was designed as a prospective cross-sectional study during the period from May 2018 to October 2019. The study included hypospadias patients who were admitted to a hypospadias clinic at a university hospital.
Inclusion criteria were that a child complained of primary distal or mid-penile hypospadias at age 6 months or more, had a urethral plate less than 8 mm, and had a non-circumcised penis. Children with redo hypospadias, significant Chordee (30 percent or more), non-preservable plates, circumcised patients, and proximal hypospadias were excluded.
History...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inclusion criteria were that a child complained of primary distal or mid-penile hypospadias at age 6 months or more, had a urethral plate less than 8 mm, and had a non-circumcised penis.
- Exclusion Criteria:
- • . Children with redo hypospadias, significant Chordee (30 percent or more), non-preservable plates, circumcised patients, and proximal hypospadias were excluded.
About Sarah Magdy Abdelmohsen
Sarah Magdy Abdelmohsen is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, she leads initiatives that prioritize scientific rigor and ethical standards in clinical trials. Her extensive experience in trial design, regulatory compliance, and patient engagement ensures that studies not only meet stringent industry guidelines but also address the real-world needs of diverse patient populations. Under her guidance, research efforts aim to contribute valuable insights to the medical community and foster the development of effective treatments across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials